Moderna's sky-high value is an indictment of the U.S. Covid-19 response

Moderna's sky-high value is an indictment of the U.S. Covid-19 response

STAT Plus: Moderna’s skyrocketing market value is an indictment of the U.S. Covid-19 response

By ADAM FEUERSTEIN

RUBY WALLAU FOR STAT

Moderna is now one of the most valuable biopharma companies. That's a remarkable achievement, but also an indictment of the U.S. pandemic response.

READ MORE